Triple therapy should not be necessary for most patients with COPD but the concern about overprescription remains. Dr Eli Dabscheck, a respiratory physician at the Alfred Hospital, Melbourne, and co-chair of the national COPD-X guidelines committee, said evidence that inhaled corticosteroids (ICS) were already overprescribed supported those concerns. Speaking at the Respiratory Insights Forum in ...
Support for stepwise approach to COPD
16 Jul 2018
Sponsored by A. Menarini Australia Pty Ltd